Effects of replacement fluids on coagulation system used for therapeutic plasma exchange

Transfusion and Apheresis Science

Volumn 28, Issue 1, 2003, Pages 3-7

  Tek, Ibrahim ^a   Arslan, Önder ^a   Arat, Mutlu ^a   Özcan, Muhit ^a   Akdaǧ, Beyza ^b   Ilhan, Osman ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Coagulation factors; Plasma exchange; Replacement solutions

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; D DIMER; FIBRINOGEN; HETASTARCH; PROTEIN C; PROTEIN S; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LIQUID; MALE; PLASMAPHERESIS; PROTHROMBIN TIME; SIDE EFFECT; STATISTICAL ANALYSIS; SUBSTITUTION THERAPY; THROMBIN TIME;

EID: 0037293231     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-0502(02)00093-9     Document Type: Article

References (15)

1. Norda R., Berseus O., Stegmayr B. Advers events and problems in therapeutic hemapheresis. A report from the Swedish registry. Transfus Apheresis Sci. 25:2001;33-41.
2. Le Conte P., Nicolas F. Replacement fluids in plasmapheresis: cross-over comparative study. Intensive Care Med. 23:1997;34.
3. Reimann P.M., Mason P.D. Plasmapheresis: technique and complication. Intensive Care Med. 337:1990;395-397.
4. Domen R.E., Kennedy M.S. Hemostatic imbalances produced by plasma exchange. Transfusion. 24:1984;336-339.
5. Stump D.C., Strauss R.G. Effects of hydroxyethyl starch on blood coagulation, particularly factor VIII. Transfusion. 25:1985;349-354.
6. Misher J.M. Pharmacology of hydroxyethyl satrch. 1982;Oxford Universty Press, Oxford.
7. Strauss R.G., Koepke J.A. Clinical and laboratory effects on donors of intermittent-flow centrifugation, platelet-leukopheresisi performed with hydroxyethyl starch and citrate. Clin Lab Haematol. 2:1980;1-11.
8. Weinstein R. Basic principles of therapeutic blood exchange Apheresis: principles and practice. 1997;AABB press, Bethesda, MD. p. 272-75.
9. Keller A.J., Chrinside A. Coagulation abnormalities produced by plasma exchange on the cell separator with special reference to fibrinogen and platelet levels. Br J Haematol. 42:1979;593-603.
10. Berkman E.M., Orlin J.B. Use of plasmapheresis and partial plasma exchange in the management of patients with cryoglobulinemia. Transfusion. 56:1980;171-178.
11. Wood L., Jacobs P. The effect of serial therapeutic plasmapheresis on platelet count, coagulation factors, plasma immunglobulin, and complement levels. J Clin Apheresis. 3:1986;124-128.
12. Domen R.E. Hemostatic imbalances produced by plasma exchange. Transfusion. 24:1984;336-339.
13. Sutton D.M., Nair R.C. Complications of plasma exchange. Transfusion. 29:1989;124-127.
14. Arslan, Ö, Tombulog̀lu M, Karadog̀an I, Kiliç B, Çetin M, Başlamiş F, et al. National Survey of Total Plasma Exchange In Turkey, 1998. ASFA's 21st Annual Meeting Final Programme, 6-8 April 2000, Las Vegas, Nevada.
15. Arslan Ö, Arat M, ilhan O. Therapeutic plasma exchange and clinical application, definition and the history. Turkish J Hematol, in press.